Get started
RocketTickers

Genprex Receives U.S. FDA Fast Track Designation for REQORSA™ Im

Long
Genprex, Inc. (NASDAQ:GNPX)  
RocketTickers  
NASDAQ:GNPX   Genprex, Inc.
Beyond Technical Analysis
2
1
beyondta
GNPX: Genprex, Inc.
2022-01-03 08:00:00
Genprex Receives U.S. FDA Fast Track Designation for REQORSA™ Immunogene Therapy in Combination With Keytruda® for the Treatment of Non-Small Cell Lung Cancer
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.